Barnes Group (B) 34.52 $B Barnes Group Inc. Declares

New Post Public Reply Private Reply Replies (0) Message Board

Jun 13, 2016 at 4:12 AM

Barnes Group ( 34.52 $B

Barnes Group Inc. Declares Increased Quarterly Dividend
BusinessWire - Fri May 06, 8:50AM CDT
The Board of Directors of Barnes Group Inc. (NYSE: today increased the Company's quarterly cash dividend 8 percent to thirteen cents ($0.13) per share of common stock. The dividend will be payable June 10, 2016 to shareholders of record at the close of business on May 26, 2016. The dividend increase will raise the annualized dividend payout to $0.52 per share of common stock.
B: 34.52 (-0.25)

Barnes Group meets 1Q profit forecasts
Automated Insights - Mon Apr 25, 3:53PM CDT
BRISTOL, Conn. (AP) _ Barnes Group Inc. ( on Monday reported first-quarter net income of $28.8 million.
B: 34.52 (-0.25)

Barnes Group Inc. Reports First Quarter 2016 Financial Results
BusinessWire - Mon Apr 25, 3:25PM CDT
--Operating Margin of 14.4%; Adjusted Operating Margin of 14.7%, down 20 bps
B: 34.52 (-0.25)

Upgrade Alert for Barnes Group (
Comtex SmarTrend(R) - Fri Apr 08, 3:40AM CDT
Barnes Group (NYSE: was upgraded from Hold to Buy at Deutsche Bank today. The stock closed yesterday at $34.72 on volume of 753,000 shares, above average daily volume of 194,000. Barnes Group has overhead space with shares priced $34.72, or 19.3% below the average consensus analyst price target of $43.00. The stock should find resistance at its 200-day moving average (MA) of $36.40, as well as support at its 50-day MA of $33.46.
B: 34.52 (-0.25)

Barnes Group Inc. Announces First Quarter 2016 Earnings Conference Call and Webcast
BusinessWire - Wed Mar 16, 12:41PM CDT
Barnes Group Inc. (NYSE: today announced it will release first quarter 2016 financial results on Friday, April 29, 2016, before the market opens.
B: 34.52 (-0.25)

Stock Market News for March 02, 2016
Zacks Equity Research - Zacks Investment Research - Wed Mar 02, 9:10AM CST
Benchmarks finished in the green following sharp rally in oil prices and encouraging economic data.
F: 13.10 (-0.16), PRU: 73.54 (-1.61), B: 34.52 (-0.25), C: 43.90 (-1.11), XOM: 89.98 (-0.69), WFC: 48.34 (-0.80), BAC: 13.83 (-0.36), RRC: 43.21 (-3.00), SLB: 78.53 (-1.43), PXD: 159.55 (-4.65), GS: 149.89 (-3.28), JPM: 63.84 (-0.91), CHK: 4.42 (-0.46), CVX: 101.98 (-0.83), AAPL: 98.83 (-0.82), APC: 53.00 (-1.48)

Barnes Group misses Street 4Q forecasts
Automated Insights - Fri Feb 19, 5:47AM CST
BRISTOL, Conn. (AP) _ Barnes Group Inc. ( on Friday reported fourth-quarter net income of $24.4 million.
B: 34.52 (-0.25)

Barnes Group Inc. Declares Quarterly Dividend
BusinessWire - Wed Feb 10, 9:32AM CST
The Board of Directors of Barnes Group Inc. (NYSE: has declared a quarterly cash dividend of twelve cents ($0.12) per share. The dividend will be payable March 10, 2016 to shareholders of record at the close of business on February 25, 2016.
B: 34.52 (-0.25)

U.S. Aircraft Engine And Engine Parts Market - Analysis And Forecast to 2020
M2 - Mon Jan 25, 10:33AM CST
Research and Markets (http://www.researchandmarkets.com/research/xwgl9b/u_s_aircraft) has announced the addition of the "U.S. Aircraft Engine And Engine Parts Market - Analysis And Forecast to 2020" report to their offering. The report provides an in-depth analysis of the U.S. Aircraft Engine And Engine Parts market. It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. In addition, the report contains insightful information about the industry, including industry life cycle, business locations, productivity, employment and many other crucial aspects. The Company Profiles section contains relevant data on the major players in the industry. Product coverage: - Military aircraft engines (including other aircraft engines built to military specifications) - Civilian aircraft engines - Aeronautical services on aircraft engines - Aircraft engine parts and accessories - Aircraft engine and engine parts manufacturing Key Topics Covered: 1. Introduction 2. Executive Summary 3. Market Overview 4. Domestic Production 5. Imports 6. Exports 7. Competitive Landscape 8. Company Profiles - Honeywell International - Rolls-Royce Corporation - AAR Corp. - Walbar - Heico Corporation - Chromalloy Gas Turbine - Barnes Group - Continental Motors - Turbine Engine Components Technologies - Utica Corporation - ITT Enidine - Sifco Industries - Triumph Composite Systems - Edac Technologies Corporation - Pratt and Whitney - Cfan Company - Meyer Tool - GKN Aerospace Chem-Tronics - GE Aviation Muskegon - Avio - CTS Electronic Components - Sequa Corporation - Valent Aerostructures - Heligear Acquisition Co. - Heico Aerospace Holdings Corp. - Ducommun Aerostructures - Strategic Industries - Yulista Aviation - Heico Aerospace Corporation - Advanced Atomization Technologies - Gb Aero Engine - HM Dunn Aerosystems For more information visit http://www.researchandmarkets.com/research/xw...s_aircraft
HON: 116.68 (-0.53), DCO: 19.06 (+1.75), B: 34.52 (-0.25), AIR: 24.19 (-0.08)

Barnes Group Inc. Announces Fourth Quarter and Full Year 2015 Earnings Conference Call and Webcast
BusinessWire - Wed Dec 16, 1:00PM CST
Barnes Group Inc. (NYSE: today announced it will release fourth quarter and full year 2015 financial results on Friday, February 19, 2016, before the market opens.
B: 34.52 (-0.25)

Kaman Segment Boosts Bearing Business on GRW Buyout
Zacks Equity Research - Zacks Investment Research - Wed Nov 11, 1:55PM CST
Premium industrial goods company Kaman Corporation (KAMN) continues to ride on the growth track with lucrative inorganic deals.
B: 34.52 (-0.25), MIDD: 124.54 (-1.53), AIMC: 28.09 (-0.51), KAMN: 43.10 (-0.31)

Blount International Beats Q3 Earnings, Lags on Revenues
Zacks Equity Research - Zacks Investment Research - Wed Nov 11, 8:20AM CST
Blount International Inc's (BLT) third-quarter 2015 earnings of 25 cents per share surpassed the Zacks Consensus Estimate of 20 cents; while net sales of $209 million lagged the Zacks Consensus Estimate of $230 million.
B: 34.52 (-0.25), MIDD: 124.54 (-1.53), AIMC: 28.09 (-0.51), BLT: 10.00 (+0.02)

Richard R. Barnhart Announces Plans to Retire as Senior Vice President, Barnes Group Inc. and President, Barnes Aerospace
BusinessWire - Wed Nov 04, 3:15PM CST
Barnes Group, Inc. (NYSE: today announced that Richard R. Barnhart has notified the Company of his intention to retire as Senior Vice President, Barnes Group Inc. and President, Barnes Aerospace at the end of June 2016.
B: 34.52 (-0.25)

Will Owens-Illinois' (OI) Q3 Earnings Surprise Investors?
Zacks Equity Research - Zacks Investment Research - Mon Oct 26, 3:17PM CDT
Owens-Illinois, Inc. (OI) is slated to release third-quarter 2015 results after the market closes on Oct 27.
HSC: 6.53 (-0.33), OI: 19.43 (-0.49), B: 34.52 (-0.25), HDS: 34.70 (-1.59)

Altra Industrial Beats on Q3 Earnings, Cuts '15 Outlook
Zacks Equity Research - Zacks Investment Research - Mon Oct 26, 9:00AM CDT
Altra Industrial Motion Corporation's (AIMC) non-GAAP earnings came in at 43 cents per share in third-quarter 2015, down 4.4% year over year but surpassing the Zacks Consensus Estimate of 40 cents.
GHM: 18.42 (-0.04), B: 34.52 (-0.25), MIDD: 124.54 (-1.53), AIMC: 28.09 (-0.51)

New Strong Buy Stocks for October 23rd
Zacks Equity Research - Zacks Investment Research - Fri Oct 23, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
BGS: 45.21 (-0.54), B: 34.52 (-0.25), CAR: 32.86 (-1.34), CRI: 101.72 (-2.62), CALD: 19.72 (-0.11)

Barnes Group Inc. Reports Third Quarter 2015 Financial Results
BusinessWire - Fri Oct 23, 5:30AM CDT
--Operating Margin of 15.0%; Adjusted Operating Margin of 16.6%, up 10 bps
B: 34.52 (-0.25)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Clarins Dazzles Austin with Skin Longevity Event

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Innovent's IBI3001 Shows Promise in Phase 1 Trials

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Sinclair Faces Labor Lawsuit for Break-time Violations

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Gildan Activewear Faces Legal Battle Over Alleged Fraud

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...